![Donna Grogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donna Grogan
Direktor/Vorstandsmitglied bei
C4 THERAPEUTICS, INC.
Vermögen: 327 108 $ am 31.05.2026
Profil
Donna Roy Grogan is currently Independent Director at C4 Therapeutics, Inc. since 2022 and President at Clementia Pharmaceuticals USA, Inc. since 2014.
Former roles include Independent Director at Momenta Pharmaceuticals, Inc. from 2019 to 2020; Medical Director at Astra Pharmaceuticals, Inc.; Senior Vice President-Clinical Research at Sumitomo Pharma America, Inc. from 2000 to 2007; Chief Medical Officer at DecImmune Therapeutics, Inc., Apofore Corp., Anexon, Inc.; Chief Medical Officer at Clementia Pharmaceuticals, Inc. from 2013 to 2019; and Chief Medical Officer at FoldRx Pharmaceuticals LLC from 2007 to 2010.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts) and a doctorate from the University of Illinois College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.07.2026 | 74’853 ( 0.07% ) | 327 108 $ | 31.05.2026 |
Aktive Positionen von Donna Grogan
| Unternehmen | Position | Beginn |
|---|---|---|
| C4 THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 29.07.2022 |
Clementia Pharmaceuticals USA, Inc.
 Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Präsident | 01.06.2014 |
Ehemalige bekannte Positionen von Donna Grogan
| Unternehmen | Position | Ende |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| CLEMENTIA PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2011 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01.01.2007 |
DecImmune Therapeutics, Inc.
 DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Donna Grogan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Health Technology |
DecImmune Therapeutics, Inc.
DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Health Technology |
Apofore Corp.
 Apofore Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for diabetes | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astra Pharmaceuticals, Inc. | |
Anexon, Inc.
 Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
University of Illinois College of Medicine
 University of Illinois College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Clementia Pharmaceuticals USA, Inc.
Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Wählen Sie MarketScreener 
